VANCOUVER, British Columbia, June 18, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Restricted (“Ketamine One” or the “Firm”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), an organization centered on consolidating medical clinics and changing into a North American chief in psychological well being remedies and related analysis, is happy to announce that it has not too long ago engaged a small variety of arm’s size service suppliers to help with investor relations, media and public consciousness.
First, CanaComGroup (“CCG”) has been engaged to supply an investor consciousness program to have interaction with the web neighborhood and assist obtain a greater understanding of Ketamine One (“CCG Providers”) for a interval of six months, topic to the phrases of the service settlement (the “CCG
Settlement”) entered into between the MEDI and CCG. Pursuant to the CCG Settlement, CCG can be paid an up-front money quantity of $50,000 plus Items and Providers Tax (“GST”) for the CCG Providers to be offered over the six-month time period.
Second, the Firm has engaged CFN Enterprises Inc. (“CFN Media”), to supply investor relations and media companies (the “CFN Media Providers”) for an preliminary time period of three months, topic to the phrases of the service settlement (the “CFN Media Settlement”) entered into between the MEDI and CFN Media. Pursuant to the phrases of the CFN Media Settlement, CFN Media can be paid an aggregated money charge of US $27,000 over the three-month time period. For extra details about CFN Media, please go to https://www.cannabisfn.com/.
Third, the Firm has engaged Proactive Buyers North America Inc. (“Proactive”), to help the Firm in enhancing its on-line profile with the worldwide funding neighborhood (the “Proactive Providers”) for a interval of 13 months, topic to the phrases of the service settlement (the “Proactive Settlement”) executed between the Firm and Proactive. Pursuant to the phrases of the Proactive Settlement, Proactive can be paid an up-front money quantity of $25,000 plus GST for the Proactive Providers to be offered over the 13-month time period.
The Firm additionally pronounces that topic to acceptance by the NEO Trade, it has granted an combination of fifty,000 inventory choices (the “Choices”) to a director to buy as much as 50,000 widespread shares of the Firm at a value of $1.70 per widespread share for a interval of 5 years from the date of grant, pursuant to its Inventory Choice Plan that was authorized by shareholders on February 21, 2021. 50% of the Choices vest six months from the date of grant with the remaining 50% of the Choices vesting twelve months after the date of the grant.
ABOUT KETAMINE ONE
KetamineOne Capital Restricted (previously Myconic Capital Corp.) (NEO: MEDI) is an organization centered on consolidating medical clinics and changing into a North American chief in psychological well being remedies. It’s working to supply the vital infrastructure wanted to develop and ship breakthrough psychological well being remedies. Presently, Ketamine One has a community of 15 clinics throughout North America, with plans to additional consolidate the extremely fragmented trade. The latest addition of KGK Science Inc. because the Firm’s contract analysis division additionally locations the corporate on the forefront of premium scientific analysis primarily based on its 23-year historical past and in depth expertise in prescription drugs, hashish, and the rising psychedelic drugs industries. As a collective enterprise, Ketamine One is devoted to serving to remedy the rising want for secure and accessible psychological well being remedy.
On behalf of:
Robert Meister, CEO and Director
For additional data, please contact:
Nick Kuzyk, Investor Relations
Tel: 1-844-PHONE-K1 (1-844-746-6351)
E mail: IR@ketamine.one
Discover Concerning Ahead-Trying Data:
This information launch comprises forward-looking statements together with however not restricted to statements relating to the Firm’s enterprise, belongings or investments, as effectively different statements that aren’t historic information. Readers are cautioned to not place undue reliance on forward-looking statements, as there will be no assurance that the plans, intentions or expectations upon which they’re primarily based will happen. By their nature, forward-looking statements contain quite a few assumptions, identified and unknown dangers and uncertainties, each basic and particular, that contribute to the chance that the predictions, forecasts, projections and different forward-looking statements is not going to happen, which can trigger precise efficiency and ends in future intervals to vary materially from any estimates or projections of future efficiency or outcomes expressed or implied by such forward-looking statements. These assumptions, dangers and uncertainties embrace, amongst different issues, the state of the financial system normally and capital markets particularly, investor curiosity within the enterprise and future prospects of the Firm.
The forward-looking statements contained on this information launch are made as of the date of this information launch. Besides as required by legislation, the Firm disclaims any intention and assumes no obligation to replace or revise any forward-looking statements, whether or not because of new data, future occasions or in any other case, besides as required by relevant securities legislation. Moreover, the Firm undertakes no obligation to touch upon the expectations of, or statements made, by third events in respect of the issues mentioned above.